BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19056723)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research in end-of-life settings: an ethical inquiry.
    LeBlanc TW; Wheeler JL; Abernethy AP
    J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):244-50. PubMed ID: 20718645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical issues in research outsourcing.
    Acharya S
    J Dent Educ; 2007 Apr; 71(4):447-8. PubMed ID: 17468303
    [No Abstract]   [Full Text] [Related]  

  • 24. Playing roulette with experimental drugs.
    Budiansky S
    US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Defining an ethics for preventive trials].
    Chippaux JP
    Bull Soc Pathol Exot; 2008 Apr; 101(2):85-9. PubMed ID: 18543698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical issues in palliative care: considerations.
    Manima A
    J Pain Palliat Care Pharmacother; 2003; 17(3-4):141-9; discussion 151-2. PubMed ID: 15022958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 31. Access to medicines in developing countries: ethical demands and moral economy.
    Cassier M; Correa M
    Dev World Bioeth; 2014 Aug; 14(2):ii-viii. PubMed ID: 25039326
    [No Abstract]   [Full Text] [Related]  

  • 32. Access to experimental drugs in terminally ill patients: a new idea?
    Enck RE
    Am J Hosp Palliat Care; 2010 Dec; 27(8):509-10. PubMed ID: 20826495
    [No Abstract]   [Full Text] [Related]  

  • 33. The ethics of end-of-life research.
    Fine PG
    J Pain Palliat Care Pharmacother; 2004; 18(1):71-8. PubMed ID: 15148010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethical considerations in industry-sponsored multiregional clinical trials.
    Ibia E; Binkowitz B; Saillot JL; Talerico S; Koerner C; Ferreira I; Agarwal A; Metz C; Maman M
    Pharm Stat; 2010; 9(3):230-41. PubMed ID: 20824884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to do research fairly in an unjust world.
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ethics of research: the freedom to withdraw].
    de Cenival M
    Bull Soc Pathol Exot; 2008 Apr; 101(2):98-101. PubMed ID: 18543700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical companies vs. the State: who is responsible for post-trial provision of drugs in Brazil?
    Wang DW; Ferraz OL
    J Law Med Ethics; 2012; 40(2):188-96. PubMed ID: 22789039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 40. Enrolling the uninsured in clinical trials: an ethical perspective.
    Pace C; Miller FG; Danis M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S121-5. PubMed ID: 12626956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.